Anti-A2GL/ LRG1/ HMFT1766 functional antibody
Anti-A2GL/ LRG1/ HMFT1766 functional antibody for cell culture, ELISA & in-vivo assay
Go to LRG1/LRG1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE1081-Ab-1/ GM-Tg-hg-SE1081-Ab-2 | Anti-Human LRG1 monoclonal antibody | Human |
GM-Tg-rg-SE1081-Ab-1/ GM-Tg-rg-SE1081-Ab-2 | Anti-Rat LRG1 monoclonal antibody | Rat |
GM-Tg-mg-SE1081-Ab-1/ GM-Tg-mg-SE1081-Ab-2 | Anti-Mouse LRG1 monoclonal antibody | Mouse |
GM-Tg-cynog-SE1081-Ab-1/ GM-Tg-cynog-SE1081-Ab-2 | Anti-Cynomolgus/ Rhesus macaque LRG1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE1081-Ab-1/ GM-Tg-felg-SE1081-Ab-2 | Anti-Feline LRG1 monoclonal antibody | Feline |
GM-Tg-cang-SE1081-Ab-1/ GM-Tg-cang-SE1081-Ab-2 | Anti-Canine LRG1 monoclonal antibody | Canine |
GM-Tg-bovg-SE1081-Ab-1/ GM-Tg-bovg-SE1081-Ab-2 | Anti-Bovine LRG1 monoclonal antibody | Bovine |
GM-Tg-equg-SE1081-Ab-1/ GM-Tg-equg-SE1081-Ab-2 | Anti-Equine LRG1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE1081-Ab-1/ GM-Tg-hg-SE1081-Ab-2; GM-Tg-rg-SE1081-Ab-1/ GM-Tg-rg-SE1081-Ab-2; GM-Tg-mg-SE1081-Ab-1/ GM-Tg-mg-SE1081-Ab-2; GM-Tg-cynog-SE1081-Ab-1/ GM-Tg-cynog-SE1081-Ab-2; GM-Tg-felg-SE1081-Ab-1/ GM-Tg-felg-SE1081-Ab-2; GM-Tg-cang-SE1081-Ab-1/ GM-Tg-cang-SE1081-Ab-2; GM-Tg-bovg-SE1081-Ab-1/ GM-Tg-bovg-SE1081-Ab-2; GM-Tg-equg-SE1081-Ab-1/ GM-Tg-equg-SE1081-Ab-2 |
Products Name | Anti-LRG1 monoclonal antibody |
Format | mab |
Target Name | LRG1 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-LRG1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE1081-Ag-1 | Recombinant multi-species A2GL/ LRG1/ HMFT1766 protein |
ORF Viral Vector | pGMLV000043 | human LRG1 Lentivirus plasmid |
ORF Viral Vector | vGMLV000043 | human LRG1 Lentivirus particle |
ORF Viral Vector | pGMLPm004935 | mouse Lrg1 Lentivirus plasmid |
ORF Viral Vector | vGMLPm004935 | mouse Lrg1 Lentivirus particle |
Target information
Target ID | GM-SE1081 |
Target Name | LRG1 |
Gene ID | 116844,76905,367455,693859,611876,101082129,514663,111774184 |
Gene Symbol and Synonyms | 1300008B03Rik,2310031E04Rik,HMFT1766,LRG,LRG1,Lrhg |
Uniprot Accession | P02750 |
Uniprot Entry Name | A2GL_HUMAN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | Ovary Cancer, Nephrotic syndrome, Non-small cell lung carcinoma, Acute appendicitis, Appendicitis, Contrast - Induced Nephropathy, Diabetic Nephropathy, Malignant neoplasm of bladder |
Gene Ensembl | ENSG00000171236 |
Target Classification | N/A |
The target: LRG1, gene name: LRG1, also named as HMFT1766, LRG. The leucine-rich repeat (LRR) family of proteins, including LRG1, have been shown to be involved in protein-protein interaction, signal transduction, and cell adhesion and development. LRG1 is expressed during granulocyte differentiation (O'Donnell et al., 2002 [PubMed 12223515]).[supplied by OMIM, Mar 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.